The Filing Desk

CareDx vs Starling Oncology

CareDx CDNA · Starling Oncology STLN · Health Care Services

Starling Oncology reported revenue of $503 million in fiscal 2025, 1.3 times CareDx's $380 million in fiscal 2025. CareDx's revenue grew 13.8% in its latest year, and Starling Oncology's grew 27.8%. CareDx had an operating margin of -8.1%, against -7.2% at Starling Oncology.

Side by side

CareDxStarling Oncology
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$380M$503M
Revenue growth13.8%27.8%
Revenue growth a year, last 5 years14.6%21.8%
Gross margin——
Operating margin−8.1%−7.2%
Net margin−5.6%−12.1%
Free cash flow—−$28M
Free cash flow margin—−5.5%
Return on capital−20.0%−75.7%
Net debt to EBITDA——
Dividends and buybacks$88M$0M
Change in diluted share count−5.9%23.1%
Last close$77.88$3.50
P/E at the last close32.6×—
Insider trades, last 12 monthssold $13.6 million—
Piotroski F-score4 of 83 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CareDxStarling Oncology
Operating margin
Percent of revenue
CareDxStarling Oncology
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CareDxStarling Oncology

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CareDx and Starling Oncology pages.